Nishida, Mutsumi, Iwai, Takahito, Sato, Megumi, Kudo, Yusuke, Omotehara, Satomi, Horie, Tatsunori, Sakano, Ryosuke, Yasumoto, Atsushi, Goto, Hideki, and Teshima, Takanori
Sinusoidal obstruction syndrome (SOS) / hepatic veno-occlusive disease (VOD) is a serious complication after hematopoietic stem cell transplantation (HSCT). Incidence of SOS/VOD after HSCT varies from 5 to 60%1-4, and mortality rate was 80%2, if it's with multiorgan failure. Difibrotide is only a drug for SOS/VOD treatment, approved by the Ministry of Health, Labour and Welfare in Japan. Early diagnosis, and prompt initiation of defibrotide thought to be successful treatment of SOS/VOD5. The diagnostic criteria of SOS/VOD were based on clinical findings, such as body weight gain and hyperbirilubinemia. Recently, ultrasonography (US) has been suggested as one of modalities to diagnose SOS/VOD. We previously reported the usefulness of original US scoring system, which includes assessing hepatomegaly, ascites, and blood flow alteration. It is called Hokkaido US-based scoring system (HokUS) -106 in diagnosing SOS/VOD. And it has been suggested as one of criteria to diagnose SOS in European federation of bone marrow transplantation (EBMT) guideline 20237. However, 10 findings of HokUS-10 are rather many, and prominent findings are needed for diagnosing SOS/VOD. To identify prominent findings of HokUS-10 for diagnosing SOS. The patients who underwent HSCT from Jan. 2008 to June 2019 in our institution were retrospectively analyzed. HokUS-10 were applied to the patients before HSCT and on day 14, 28 or when the signs of SOS appeared after HSCT (Fig.1). SOS was clinically diagnosed by the modified Seattle8 or the Baltimore criteria9 or the EBMT criteria10. Patients developed SOS within 21 days after HSCT was categorized as classical SOS, and byond 21 days was as late-onset SOS. HokUS-10 consists of 10 parameters were used SOS/VOD diagnosis (Table 1) US was performed using PVT-375 BT (center frequency, 3.75 MHz), PVT-674 BT (center frequency, 6 MHz), and PVT-704 BT (center frequency, 7.5 MHz) equipped with Aplio™ XV/XG/500/Xario/i800/i700 (Canon Medical Systems Corp., Otawara, Japan), by 5 registered medical sonographers (1∼26 years experiment of US). To clarify most prominent parameters in HokUS-10, diagnostic performance and Odds ratio were analyzed in classical and late-onset SOS. Four hundred and forty-one until day 21 and 421 patients after day 22 of HSCT were enrolled. Of whom, 30 and 22 patients were diagnosed by clinically as classical and late-onset SOS, respectively. Ascites showed highest sensitivity as 100% in both classical and late-onset SOS. Highest positive predictive value as 100% was seen in hepatofugal portal vein blood flow signal. Odds ratio, of classical and late-onset SOS of moderate amount of ascites, appearance of PUV blood flow signal, PUV dilatation, decrease of PV blood flow velocity, and GB wall thickness were 317.3 and 85.5, 41.6 and 32.1, 29.7 and 27.8, 12.6 and 30.6, and 27.4 and 6.6, respectively, in descending order. Prominent findings of HokUS-10 for diagnosing both of clinical and late-onset SOS were moderate amount of ascites, PUV dilatation, and appearance of PUV blood flow signal in descending order. Also, in classical SOS, GB wall thickening, and in late-onset SOS decrease of PV blood flow velocity were followed by prominent findings. [ABSTRACT FROM AUTHOR]